All Type of News
Multinationals have positive views on Korean drug makers
Overall, foreign-invested pharmaceutical firms feel that domestic pharmaceutical firms have performed their business operations well in terms of production facilities, licensing procedures and sales activities, accord...
Some multinationals to stage uphill battle in maintaining initial insurance price
Despite their favorable ruling over the trial to confirm the scope of patent rights, some multinational drug manufacturers, such as Pfizer and Sanofi-Aventis, are unlikely to see their reduced insurance prices to the ...
Cervarix, GSK's cervical cancer vaccine, approved in Korea
GlaxoSmithKline (GSK) says that the Korea Food and Drug Administration has granted a marketing authorization for its cervical cancer vaccine, Cervarix.
Cervarix, with its innovative AS04 adjuvant system, is indica...
Plavix generics market steams up
Plavix generics market steams up
The domestic market of Sanofi-Aventis’s Plavix (clopidogrel) generic market has been gaining momentum as smaller manufacturers see opportunities in the field where t...
Park named Janssen China chiefPark Je-wha, former president of Janssen Korea will be appointed CEO of Janssen China as of August 1, this year.
Park, 57, will also become regional CEO covering Taiwan and H...
|
Positive list system faces backlash
The Health Insurance Review & Assessment Service will have to re-evaluate the economic effectiveness of antihyperlipemic agents, as 20 pharmaceutical firms – Pfizer Korea, AstraZeneca Korea and Novartis Korea – asked ...
Hospital pharmacists urge government to select new students
The Korean Society of Health System Pharmacists has rolled its sleeves to revamp the controversial six-year pharmacy college system.
In a recent meeting with officials of the Ministry of Education, Science and Tech...
Dong-A signs $168 million export dealDong-A Pharmaceutical signed export contracts for Zydena, the erectile dysfunction treatment, with a total of 16 countries including Brazil and Malaysia worth $168 million
Th...
|
Medical costs for elderly patients top 1.7 trillion won in 2007
The treatment costs for patients with illnesses associated with old age surged 192.5 percent from 580 billion won in 2004 to total 1.7 trillion won in 2007, according to the National Health Insurance Corporation.
T...
Lilly Korea launches ActosMet
Lilly Korea says it has launched its ActosMet (Actos 15 mg + metformin 850 mg) tablets for treatment of 2 diabetes - namely insulin resistance.
Actos is a clinically proven, once a day medicine that belongs to a cl...
